EBITDA: Income before interest, taxes, depreciation and amortization.
IO Biotech, Inc. (IOBT) had EBITDA of $-23.11M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-26.22M |
|
-- |
|
-- |
|
$23.17M |
|
$-23.17M |
|
$-2.93M |
|
$-26.10M |
|
$-26.10M |
|
$-26.22M |
|
$-26.22M |
|
$-26.22M |
|
$-26.22M |
|
$-23.17M |
|
|
EBITDA |
$-23.11M |
65.88M |
|
65.88M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$38.98M |
|
$0.60M |
|
$3.35M |
|
$42.33M |
|
$19.90M |
|
$6.72M |
|
$20.84M |
|
$40.73M |
|
$1.59M |
|
$1.59M |
|
$1.59M |
|
65.88M |
|
| Cash Flow Statement Financials | |
$-42.89M |
|
$-0.05M |
|
$11.49M |
|
$60.30M |
|
$28.40M |
|
$-31.90M |
|
$3.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.96 |
|
-- |
|
-- |
|
0.81 |
|
4.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.95M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1646.77% |
|
-1646.80% |
|
-61.94% |
|
-315.41% |
|
$0.02 |
|
$-0.65 |
|
$-0.65 |
|